Aug 15, 2025 • Benzinga
SOMEWHAT-BULLISH
Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Applied Optoelectronics ( NASDAQ:AAOI ) , Evolv Technologies ( NASDAQ:EVLV )
U.S. stocks were mixed, with the Dow Jones index gaining around 100 points on Friday. Shares of Evolv Technologies Holdings, Inc. EVLV rose sharply during Friday's session following strong quarterly results.
Aug 15, 2025 • Benzinga
NEUTRAL
Oscar Health Unusual Options Activity - Oscar Health ( NYSE:OSCR )
Benzinga's options scanner just detected over 9 options trades for Oscar Health OSCR summing a total amount of $268,474. At the same time, our algo caught 2 for a total amount of 98,151. ArrivedBuy shares of homes and vacation rentals for as little as $100. Get Started
Aug 14, 2025 • Benzinga
NEUTRAL
Oscar Health Faces Analyst Questions On Path To Profitability - Oscar Health ( NYSE:OSCR )
Piper Sandler cuts Oscar Health price target from $14 to $13. Risk adjustment for 2025 projected in mid-teen range, steady y/y. See what Wall Street is buying with instant access to ratings on 1,000 top stocks, including Goldman Sachs, Morgan Stanley, and more. Unlock all ratings now.
Aug 06, 2025 • Motley Fool
NEUTRAL
Oscar Health ( OSCR ) Q2 Revenue Rises 29%
Oscar Health ( NYSE:OSCR ) , a technology-focused health insurance provider, released results for the second quarter of 2025 on August 6, 2025, offering a mix of headline growth and operational setbacks. The most notable news: Revenue ( GAAP ) climbed 29.0% year over year to $2.86 billion, ...
Aug 06, 2025 • Benzinga
NEUTRAL
Oscar Health Unusual Options Activity - Oscar Health ( NYSE:OSCR )
Financial giants have made a conspicuous bullish move on Oscar Health. Our analysis of options history for Oscar Health OSCR revealed 17 unusual trades. Delving into the details, we found 52% of traders were bullish, while 41% showed bearish tendencies.
Aug 06, 2025 • Benzinga
NEUTRAL
Oscar Health Well-Positioned To Manage Market Reset, Eyes Profitability In 2026 - Oscar Health ( NYSE:OSCR )
Q2 revenue rose to $2.86 billion but missed estimates of $2.91 billion; EPS loss was $0.89 vs $0.86 expected. Total membership grew to 2.03 million, but operating loss widened to $230.5 million from a gain last year. The market's back, and these 3 income stocks are thriving. See them here→